Diagnosis and consequences of cocaine addiction

Current Medicinal Chemistry

Volumn 19, Issue 33, 2012, Pages 5612-5618

  Karila, L ^a   Petit, A ^b   Lowenstein, W ^c   Reynaud, M ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b BICHAT HOSPITAL   (France)

^c Addiction Treatment Center   (France)

Author keywords

Addiction; Cocaine; Cognitive impairments; Medical complications; Psychiatric complications

Indexed keywords

COCAINE;

ARTICLE; AVASCULAR NECROSIS; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COCAINE DEPENDENCE; DIFFERENTIAL DIAGNOSIS; DRUG FATALITY; DRUG OVERDOSE; EPISTAXIS; HUMAN; MENTAL DISEASE; NEUROBIOLOGY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; RESPIRATORY TRACT DISEASE; SYMPTOM; VIRUS INFECTION;

ANIMALS; CARDIOVASCULAR DISEASES; COCAINE; COCAINE-RELATED DISORDERS; COGNITION DISORDERS; COMMUNICABLE DISEASES; DOPAMINE UPTAKE INHIBITORS; HUMANS; LUNG DISEASES; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES;

EID: 84871328900     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803988839     Document Type: Article

References (100)

1. Goldstein RA, Des Lauriers C, Burda A, Johnson-Arbor K. Cocaine: history, social implications, and toxicity: a review. Semin Diagn Pathol. 2009 Feb; 26(1):10-7.
2. Cocaine: pharmacology, addiction, and therapy. Adv Alcohol Subst Abuse. 1986 Winter; 6(2):1-184.
3. UNODC. World drug report 2011, United Nations Office on Drugs and Crime, Vienna. 2011.
4. EMCDDA. European Monitoring Center for Drugs and Drug Abuse: Annual report 2011: The state of the drug problem in Europe. last access the january 12th, 2012 on www.emcdda.europa.eu. 2011.
5. Wagner FA, Anthony JC. From first drug use to drug dependence; developmental periods of risk for dependenceupon marijuana, cocaine, and alcohol. Neuropsychopharmacology 2002;26:479-88.
6. Karila L, Beck F, Legleye S, Reynaud M. [Cocaine: from recreational use to dependence]. Rev Prat. 2009 Jun. 20;59(6):821-5.
7. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002 Oct; 159(10):1642-52.
8. Dackis CA, O'Brien CP. Cocaine dependence: a disease of the brain's reward centers. J Subst Abuse Treat. 2001 Oct; 21(3):111-7.
9. Haas C, Karila L, Lowenstein W. [Cocaine and crack addiction: a growing public health problem]. Bull Acad Natl Med. 2009 Apr; 193(4):947-62; discussion 62-3.
10. Goldstein RA, Des Lauriers C, Burda AM. Cocaine: history, social implications, and toxicity-a review. Dis Mon. 2009 Jan; 55(1):6-38.
11. Panikkar G P. Cocaine Addiction: Neurobiology and Related Current Research in Pharmacotherapy. Subst Abus. 1999 Sep; 20(3):149-66.
12. Koob G, Le Moal M. Drug addiction, dysregulation of reward, and allostasis.. Neuropsychopharmacology 2001;24(2):97-129.
13. Nestler E. Molecular neurobiology of addiction.. Am J Addict. 2001;10:201-17.
14. Cami J, Farre M. Drug addiction. N Engl J Med. 2003 Sep. 4;349(10):975-86.
15. Lhuillier L, Mombereau C, Cryan JF, Kaupmann K. GABA (B) Receptor-Positive Modulation Decreases Selective Molecular and Behavioral Effects of Cocaine. Neuropsychopharmacology. 2006 May 17.
16. Arnold JC. The role of endocannabinoid transmission in cocaine addiction. Pharmacol Biochem Behav. 2005 Jun; 81(2):396-406.
17. Wiskerke J, Pattij T, Schoffelmeer AN, De Vries TJ. The role of CB1 receptors in psychostimulant addiction. Addict Biol. 2008 Jun; 13(2):225-38.
18. Williams MJ, Adinoff B. The role of acetylcholine in cocaine addiction. Neuropsychopharmacology. 2008 Jul; 33(8):1779-97.
19. Lee B, Tiefenbacher S, Platt DM, Spealman RD. Role of the hypothalamicpituitary-adrenal axis in reinstatement of cocaine-seeking behavior in squirrel monkeys. Psychopharmacology (Berl). 2003 Jul; 168(1-2):177-83.
20. Lingford-Hughes A, Nutt D. Neurobiology of addiction and implications for treatment. Br J Psychiatry. 2003;182:97-100.
21. Kalivas P W, Volkow N, Seamans J. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron. 2005 Mar. 3;45(5):647-50.
22. Crunelle CL, Miller ML, Booij J, van den Brink W. The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review. Eur Neuropsychopharmacol. 2010 Feb; 20(2):69-79.
23. Uys JD, La Lumiere RT. Glutamate: the new frontier in pharmacotherapy for cocaine addiction. CNS Neurol Disord Drug Targets. 2008 Nov; 7(5):482-91.
24. Schmidt HD, Pierce RC. Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction. Ann N Y Acad Sci. 2010 Feb; 1187:35-75.
25. Cone EJ. Pharmacokinetics and pharmacodynamics of cocaine. J Anal Toxicol. 1995 Oct; 19(6):459-78.
26. Foltin RW, Haney M. Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects. Pharmacol Biochem Behav. 2004 May; 78(1):93-101.
27. Hatsukami DK, Fischman M W. Crack cocaine and cocaine hydrochloride. Are the differences myth or reality? JAMA. 1996 Nov. 20;276(19):1580-8.
28. Karila L, Reynaud M. Addiction à la cocaïne. Médecine-Sciences F, editor. Paris: Flammarion Médecine-Sciences; 2009.
29. Dackis CA, Gold MS. Addictiveness of central stimulants. Adv Alcohol Subst Abuse. 1990;9(1-2):9-26.
30. Dackis CA. Recent advances in the pharmacotherapy of cocaine dependence. Curr Psychiatry Rep. 2004 Oct; 6(5):323-31.
31. White M, Lambe C. The pathophysiology of cocaine abuse. Journal of Clinical Forensic Medicine. 2003;10:27-39.
32. Rosenberg H. Clinical and laboratory assessment of the subjective experience of drug craving. Clin Psychol Rev. 2009 Aug; 29(6):519-34.
33. Weiss RD, Griffin ML, Mazurick C, Berkman B, Gastfriend DR, Frank A, et al. The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. Am J Psychiatry. 2003 Jul; 160(7):1320-5.
34. Lambert G, Karila L, Lowenstein W. [Neuroimaging and cocaine: mapping dependence?]. Presse Med. 2008 Apr; 37(4 Pt 2):679-88.
35. Karila L, Seringe E, Benyamina A, Reynaud M. The reliability and validity of the French version of the Cocaine Craving Questionnaire-Brief. Curr Pharm Des. 2011 May 3.
36. Wu LT, Pan JJ, Blazer DG, Tai B, Brooner RK, Stitzer ML, et al. The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. Drug Alcohol Depend. 2009 Aug. 1;103(3):114-23.
37. Mueller PD, Benowitz NL, Olson KR. Cocaine. Emerg Med Clin North Am. 1990 Aug; 8(3):481-93.
38. Karila L, Lowenstein W, Coscas S, Benyamina A, Reynaud M. [Complications of cocaine addiction]. Rev Prat. 2009 Jun. 20;59(6):825-9.
39. Schwartz BG, Rezkalla S, Kloner RA. Cardiovascular effects of cocaine. Circulation. 2010 Dec. 14;122(24):2558-69.
40. Gitter MJ, Goldsmith SR, Dunbar DN, Sharkey SW. Cocaine and chest pain: clinical features and outcome of patients hospitalized to rule out myocardial infarction. Ann Intern Med. 1991 Aug. 15;115(4):277-82.
41. Aquaro G, Gabutti A, Meini M, Prontera C, Pasanisi E, Passino C, et al. Silent myocardial damage in cocaine addicts. Heart. 2011;97(24):2056-62.
42. Finkel JB, Marhefka GD. Rethinking cocaine-associated chest pain and acute coronary syndromes. Mayo Clin Proc. 2011 Dec; 86(12):1198-207.
43. Maraj S, Figueredo VM, Lynn Morris D. Cocaine and the heart. Clin Cardiol. 2010 May; 33(5):264-9.
44. Gradman AH. Cardiac effects of cocaine: a review. Yale J Biol Med. 1988 Mar-Apr; 61(2):137-47.
45. Karch SB, Billingham ME. The pathology and etiology of cocaine-induced heart disease. Arch Pathol Lab Med. 1988 Mar; 112(3):225-30.
46. Afonso L, Mohammad T, Thatai D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am J Cardiol. 2007 Sep. 15;100(6):1040-3.
47. Tashkin D P, Kleerup EC, Hoh CK, Kim KJ, Webber MM, Gil E. Effects of 'crack' cocaine on pulmonary alveolar permeability. Chest. 1997 Aug; 112(2):327-35.
48. Gotway MB, Marder SR, Hanks DK, Leung JW, Dawn SK, Gean AD, et al. Thoracic complications of illicit drug use: an organ system approach. Radiographics. 2002 Oct; 22 Spec No: S119-35.
49. Hagan IG, Burney K. Radiology of recreational drug abuse. Radiographics. 2007 Jul-Aug; 27(4):919-40.
50. Barroso-Moguel R, Villeda-Hernandez J, Mendez-Armenta M. Medical causes and effects of cocaine abuse. Arch Invest Med (Mex). 1991 Jan-Mar; 22(1):3-8.
51. Devlin RJ, Henry JA. Clinical review: Major consequences of illicit drug consumption. Crit Care. 2008;12(1):202.
52. Das G. Cardiovascular effects of cocaine abuse. Int J Clin Pharmacol Ther Toxicol. 1993 Nov; 31(11):521-8.
53. Chow JM, Robertson AL, Jr., Stein RJ. Vascular changes in the nasal submucosa of chronic cocaine addicts. Am J Forensic Med Pathol. 1990 Jun; 11(2):136-43.
54. Wang SH, Wang HW, Wang JY. Effects of cocaine on human nasal mucosa. Eur Arch Otorhinolaryngol. 1993;250(4):245-8.
55. Goodger NM, Wang J, Pogrel MA. Palatal and nasal necrosis resulting from cocaine misuse. Br Dent J. 2005 Mar. 26;198(6):333-4.
56. King DE, Herning RI, Cadet JL. Subclinical neurological and neurovascular deficits in cocaine dependence. Gender and psychosocial considerations. Ann N Y Acad Sci. 1997 Oct. 15;825:328-31.
57. Benowitz NL. How toxic is cocaine? Ciba Found Symp. 1992;166:125-43; discussion 43-8.
58. Van Dette JM, Cornish LA. Medical complications of illicit cocaine use. Clin Pharm. 1989 Jun; 8(6):401-11.
59. Neiman J, Haapaniemi HM, Hillbom M. Neurological complications of drug abuse: pathophysiological mechanisms. Eur J Neurol. 2000 Nov; 7(6):595-606.
60. Kibayashi K, Mastri AR, Hirsch CS. Cocaine induced intracerebral hemorrhage: analysis of predisposing factors and mechanisms causing hemorrhagic strokes. Hum Pathol. 1995 Jun; 26(6):659-63.
61. Pozzi M, Roccatagliata D, Sterzi R. Drug abuse and intracranial hemorrhage. Neurol Sci. 2008 Sep; 29 Suppl 2:S269-70.
62. Konzen JP, Levine SR, Garcia JH. Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine. Stroke. 1995 Jun; 26(6):1114-8.
63. Ellis KL, Speed J. Pharmacologic management of movement disorder after midbrain haemorrhage. Brain Inj. 1998 Jul; 12(7):623-8.
64. Zhornitsky S, Stip E, Pampoulova T, Rizkallah E, Lipp O, Bentaleb LA, et al. Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia. Mov Disord. 2010 Oct. 15;25(13):2188-94.
65. Cavazos-Rehg PA, Spitznagel EL, Schootman M, Strickland JR, Afful SE, Cottler LB, et al. Risky sexual behaviors and sexually transmitted diseases: a comparison study of cocaine-dependent individuals in treatment versus a community-matched sample. AIDS Patient Care STDS. 2009 Sep; 23(9):727-34.
66. Zocratto KB, Osimani ML, Peralta LM, Latorre L, Muzzio E, Segura M, et al. Sexual behavior and HBV infection among noninjecting cocaine users (NICUs). Subst Use Misuse. 2010 Oct; 45(12):2026-44.
67. Baum M, Rafie C, Lai S, Sales S, Page B, Campa A. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. Am J Public Health. 2009;99(6):1045-9.
68. Meade CS, Conn NA, Skalski LM, Safren SA. Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence. J Behav Med. 2011 Apr; 34(2):128-38.
69. Metzger DS, Navaline H. Human immunodeficiency virus prevention and the potential of drug abuse treatment. Clin Infect Dis. 2003 Dec. 15; 37 Suppl 5:S451-6.
70. Semaan S, Neumann MS, Hutchins K, D'Anna LH, Kamb ML. Brief counseling for reducing sexual risk and bacterial STIs among drug users - results from project RESPECT. Drug Alcohol Depend. 2010 Jan 1;106(1):7-15.
71. Gourgoutis G, Das G. Gastrointestinal manifestations of cocaine addiction. Int J Clin Pharmacol Ther. 1994 Mar; 32(3):136-41.
72. Wholey MH, Ogasawara E, Ramadan MH. Acute rhabdomyolysis associated with cocaine intoxication: a case report. Hawaii Med J. 1990 Oct; 49(10):386-7.
73. Bemanian S, Motallebi M, Nosrati SM. Cocaine-induced renal infarction: report of a case and review of the literature. BMC Nephrol. 2005;6:10.
74. Gu X, Herrera GA. Thrombotic microangiopathy in cocaine abuse-associated malignant hypertension: report of 2 cases with review of the literature. Arch Pathol Lab Med. 2007 Dec; 131(12):1817-20.
75. Galea S, Nandi A, Coffin PO, Tracy M, Markham Piper T, Ompad D, et al. Heroin and cocaine dependence and the risk of accidental non-fatal drug overdose. J Addict Dis. 2006;25(3):79-87.
76. Brady KT, Lydiard RB, Malcolm R, Ballenger JC. Cocaine-induced psychosis. J Clin Psychiatry. 1991 Dec; 52(12):509-12.
77. Karila L, Petit A, Phan O, Reynaud M. [Cocaine induced psychotic disorders: a review]. Rev Med Liege. 2010 Nov; 65(11):623-7.
78. Smith MJ, Thirthalli J, Abdallah AB, Murray RM, Cottler LB. Prevalence of psychotic symptoms in substance users: a comparison across substances. Compr Psychiatry. 2009 May-Jun; 50(3):245-50.
79. Rosse RB, Fay-McCarthy M, Collins JP, Jr., Alim TN, Deutsch SI. The relationship between cocaine-induced paranoia and compulsive foraging: a preliminary report. Addiction. 1994 Sep; 89(9):1097-104.
80. Petit A, Reynaud M, Lejoyeux M, Coscas S, Karila L. [Addiction to cocaine: A risk factor for suicide?]. Presse Med. 2012 Feb. 13.
81. Roy A. Characteristics of drug addicts who attempt suicide. Psychiatry Res. 2003 Nov. 1;121(1):99-103.
82. Rounsaville BJ. Treatment of cocaine dependence and depression. Biol Psychiatry. 2004 Nov. 15;56(10):803-9.
83. Stulz N, Thase ME, Gallop R, Crits-Christoph P. Psychosocial treatments for cocaine dependence: the role of depressive symptoms. Drug Alcohol Depend. 2011 Mar. 1;114(1):41-8.
84. Johnson JE, Gibbons MB, Crits-Christoph P. Gender, race, and group behavior in group drug treatment. Drug Alcohol Depend. 2011 Dec. 15;119(3):e39-45.
85. Aronson TA, Craig TJ. Cocaine precipitation of panic disorder. Am J Psychiatry. 1986 May; 143(5):643-5.
86. Rosen MI, Kosten T. Cocaine-associated panic attacks in methadonemaintained patients. Am J Drug Alcohol Abuse. 1992;18(1):57-62.
87. Louie AK, Lannon RA, Ketter TA. Treatment of cocaine-induced panic disorder. Am J Psychiatry. 1989 Jan; 146(1):40-4.
88. Louie AK, Lannon RA, Rutzick EA, Browne D, Lewis TB, Jones R. Clinical features of cocaine-induced panic. Biol Psychiatry. 1996 Nov. 1;40(9):938-40.
89. O'Malley S, Adamse M, Heaton RK, Gawin FH. Neuropsychological impairment in chronic cocaine abusers. Am J Drug Alcohol Abuse. 1992;18(2):131-44.
90. Reske M, Delis DC, Paulus M P. Evidence for subtle verbal fluency deficits in occasional stimulant users: quick to play loose with verbal rules. J Psychiatr Res. 2011 Mar; 45(3):361-8.
91. Ardila A, Rosselli M, Strumwasser S. Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci. 1991 Mar; 57(1-2):73-9.
92. Madoz-Gurpide A, Blasco-Fontecilla H, Baca-Garcia E, Ochoa-Mangado E. Executive dysfunction in chronic cocaine users: an exploratory study. Drug Alcohol Depend. 2011 Aug. 1;117(1):55-8.
93. Jovanovski D, Erb S, Zakzanis KK. Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J Clin Exp Neuropsychol. 2005 Feb; 27(2):189-204.
94. Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes E V. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend. 2006 Feb. 28;81(3):313-22.
95. Madoz-Gurpide A, Ochoa-Mangado E. [Cognitive and executive dysfunctions in cocaine dependence: a case-control study]. Rev Neurol. 2012 Feb. 16;54(4):199-208.
96. Karila L, Gorelick D, Weinstein A, Noble F, Benyamina A, Coscas S, et al. New treatments for cocaine dependence: a focused review. Int J Neuropsychopharmacol. 2008 May; 11(3):425-38.
97. Wobrock T, Soyka M. Pharmacotherapy of schizophrenia with comorbid substance use disorder-reviewing the evidence and clinical recommendations. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug. 1;32(6):1375-85.
98. Grunze H, Vieta E, Goodwin G, Bowden C, Licht R, Möller H, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010;11(2):81-109.
99. Tiet QQ, Mausbach B. Treatments for patients with dual diagnosis: a review. Alcohol Clin Exp Res. 2007 Apr; 31(4):513-36.
100. Nic Dhonnchadha BA, Kantak KM. Cognitive enhancers for facilitating drug cue extinction: Insights from animal models. Pharmacol Biochem Behav. 2011 Feb. 2.